BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 32976981)

  • 21. The function and mechanisms of action of LOXL2 in cancer (Review).
    Wu L; Zhu Y
    Int J Mol Med; 2015 Nov; 36(5):1200-4. PubMed ID: 26329904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LOXL2-mediated matrix remodeling in metastasis and mammary gland involution.
    Barker HE; Chang J; Cox TR; Lang G; Bird D; Nicolau M; Evans HR; Gartland A; Erler JT
    Cancer Res; 2011 Mar; 71(5):1561-72. PubMed ID: 21233336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysyl Oxidase-like Protein LOXL2 Promotes Lung Metastasis of Breast Cancer.
    Salvador F; Martin A; López-Menéndez C; Moreno-Bueno G; Santos V; Vázquez-Naharro A; Santamaria PG; Morales S; Dubus PR; Muinelo-Romay L; López-López R; Tung JC; Weaver VM; Portillo F; Cano A
    Cancer Res; 2017 Nov; 77(21):5846-5859. PubMed ID: 28720577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
    Okada K; Moon HJ; Finney J; Meier A; Mure M
    Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysyl oxidase-like 2 as a new poor prognosis marker of squamous cell carcinomas.
    Peinado H; Moreno-Bueno G; Hardisson D; Pérez-Gómez E; Santos V; Mendiola M; de Diego JI; Nistal M; Quintanilla M; Portillo F; Cano A
    Cancer Res; 2008 Jun; 68(12):4541-50. PubMed ID: 18559498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
    Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
    Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
    Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
    J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients.
    Ahn SG; Dong SM; Oshima A; Kim WH; Lee HM; Lee SA; Kwon SH; Lee JH; Lee JM; Jeong J; Lee HD; Green JE
    Breast Cancer Res Treat; 2013 Aug; 141(1):89-99. PubMed ID: 23933800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-secreted LOXL2 activates fibroblasts through FAK signaling.
    Barker HE; Bird D; Lang G; Erler JT
    Mol Cancer Res; 2013 Nov; 11(11):1425-36. PubMed ID: 24008674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression.
    Liburkin-Dan T; Toledano S; Neufeld G
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
    Ye M; Song Y; Pan S; Chu M; Wang ZW; Zhu X
    Pharmacol Ther; 2020 Nov; 215():107633. PubMed ID: 32693113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LOXL2 in epithelial cell plasticity and tumor progression.
    Cano A; Santamaría PG; Moreno-Bueno G
    Future Oncol; 2012 Sep; 8(9):1095-108. PubMed ID: 23030485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and characterization of the promoter of cancer-related gene LOXL2.
    Liu X; Liu T; Hu L; Jiang T; Liu H; Wang Y; Lei Y; Zhu J; Bu Y
    Exp Cell Res; 2020 Feb; 387(2):111786. PubMed ID: 31870772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma.
    Lin S; Zheng L; Lu Y; Xia Q; Zhou P; Liu Z
    Cancer Med; 2020 Nov; 9(22):8624-8638. PubMed ID: 32970930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loxl2 is dispensable for dermal development, homeostasis and tumour stroma formation.
    Kober KI; Cano A; Géraud C; Sipilä K; Mobasseri SA; Philippeos C; Pisco AO; Stannard A; Martin A; Salvador F; Santos V; Boutros M; Rognoni E; Watt FM
    PLoS One; 2018; 13(6):e0199679. PubMed ID: 29953488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins.
    Eraso P; Mazón MJ; Jiménez V; Pizarro-García P; Cuevas EP; Majuelos-Melguizo J; Morillo-Bernal J; Cano A; Portillo F
    Molecules; 2023 May; 28(11):. PubMed ID: 37298909
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting lysyl oxidase like 2 attenuates OVA-induced airway remodeling partly via the AKT signaling pathway.
    Zeng R; Zhang D; Zhang J; Pan Y; Liu X; Qi Q; Xu J; Xu C; Shi S; Wang J; Liu T; Dong L
    Respir Res; 2024 Jun; 25(1):230. PubMed ID: 38824593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic processing of lysyl oxidase-like-2 in the extracellular matrix is required for crosslinking of basement membrane collagen IV.
    López-Jiménez AJ; Basak T; Vanacore RM
    J Biol Chem; 2017 Oct; 292(41):16970-16982. PubMed ID: 28864775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.